Jacobo Mintzer to Antidepressive Agents
This is a "connection" page, showing publications Jacobo Mintzer has written about Antidepressive Agents.
Connection Strength
0.576
-
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation. J Pharmacokinet Pharmacodyn. 2016 Feb; 43(1):99-109.
Score: 0.118
-
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences. J Geriatr Psychiatry Neurol. 2016 Mar; 29(2):59-64.
Score: 0.116
-
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. Am J Geriatr Psychiatry. 2012 Dec; 20(12):1036-44.
Score: 0.096
-
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ? 2 (DIADS-2)? Int J Geriatr Psychiatry. 2011 Jun; 26(6):573-83.
Score: 0.087
-
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry. 2010 Apr; 18(4):332-40.
Score: 0.080
-
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry. 2004 Jan; 19(1):9-18.
Score: 0.052
-
New approaches in the treatment of Alzheimer's disease. J S C Med Assoc. 1994 Nov; 90(11):553-9.
Score: 0.027